# Effects of Botulinum Neurotoxin Type A (BoNT/A) Free of Complexing Proteins in the Spastic Equinovarus Foot

> **NCT03044080** · PHASE4 · COMPLETED · sponsor: **Parc de Salut Mar** · enrollment: 20 (actual)

## Conditions studied

- Stroke Rehabilitation
- Stroke Rehabilitation Spasticity Management

## Interventions

- **DRUG:** IncobotulinumtoxinA
- **DRUG:** OnabotulinumtoxinA

## Key facts

- **NCT ID:** NCT03044080
- **Lead sponsor:** Parc de Salut Mar
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2017-06-30
- **Final completion:** 2017-09-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03044080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03044080, "Effects of Botulinum Neurotoxin Type A (BoNT/A) Free of Complexing Proteins in the Spastic Equinovarus Foot". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03044080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*